Tag - takeda

 
 

TAKEDA

Japan Times
JAPAN
Mar 5, 2021
Japan's Takeda seeks government approval for Moderna COVID-19 vaccine
While awaiting regulatory approval, Takeda plans to start distributing the Moderna vaccine in the first half of this year.
Japan Times
JAPAN
Mar 2, 2021
Moderna and Takeda to seek COVID-19 vaccine approval in Japan
The request, which could come as early as Friday, will be the third such application for regulatory approval.
Japan Times
JAPAN / Science & Health
Feb 24, 2021
Takeda starts clinical trial of Novavax COVID-19 vaccine in Japan
The drugmaker said it expects to gain results from a study on 200 Japanese participants age 20 or older in the second half of this year.
Japan Times
JAPAN
Jan 31, 2021
French judge said Japan's probe into Olympic bid bribery flawed, sources say
A French judge made the observation in Paris in December 2018 when questioning Tsunekazu Takeda, then-president of the Japanese Olympic Committee.
Japan Times
BUSINESS
Nov 20, 2020
‘Selling dog as mutton’: Mobile carriers dip on minister’s rebuke
Shares in some of the country’s largest mobile phone carriers dropped in Tokyo after the communications minister accused the companies of deploying a bait-and-switch tactic in cutting the costs of mobile phone plans.
Japan Times
JAPAN / Science & Health
Oct 29, 2020
Takeda plans to supply 50 million doses of Moderna vaccine in Japan
Takeda Pharmaceutical Co. said Thursday it plans to supply 50 million doses of a coronavirus vaccine, developed by U.S. drugmaker Moderna Inc., in Japan from the first half of next year.
Japan Times
BUSINESS / Companies
Aug 24, 2020
Takeda to sell consumer unit to Blackstone for ¥242 billion
Takeda Pharmaceutical Co. agreed to sell its Japanese consumer health care business for ¥242 billion ($2.3 billion) to Blackstone Group Inc., which plans to take the over-the-counter medication unit public in about five years.
Japan Times
BUSINESS
Aug 19, 2020
Takeda on track to sell OTC drug unit to Blackstone for ¥300 billion
Takeda is aiming to reduce debts after its purchase of Irish drugmaker Shire in January last year, the largest-ever Japanese acquisition of a foreign company.
Japan Times
BUSINESS / Companies
Jul 31, 2020
Taisho emerges as lead bidder for Takeda $3 billion consumer unit
Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.’s Japanese consumer health care business, according to people familiar with the matter.
Japan Times
BUSINESS / Companies
Jul 6, 2020
Takeda considers sale of OTC drug unit to focus on profitable products
Takeda Pharmaceutical Co. is considering selling its over-the-counter medicine unit for around ¥400 billion ($3.7 billion) to focus on developing cancer treatments and other advanced medical-use drugs that can generate higher profitability, a source said Monday.
Japan Times
BUSINESS
May 14, 2020
Takeda says trial based on blood of recovered virus patients could start in July
Fighting disease with blood from survivors is an ancient strategy that has not been well tested for the novel coronavirus.
Japan Times
BUSINESS
Mar 4, 2020
Japan's largest drugmaker working to develop virus treatment, Dow Jones reports
Takeda Pharmaceutical Co. is developing an experimental therapy for the novel coronavirus with the goal of making it available in 9 to 18 months, the nation's largest drugmaker said.
Japan Times
BUSINESS / Companies
Feb 20, 2020
As COVID-19 spreads, Takeda CEO urges more industry investment in vaccines
The spread of novel coronavirus infections is starting to make one thing clear: More vaccine investment is needed, the CEO of Asia's biggest drugmaker said.
Japan Times
JAPAN / Science & Health
Nov 7, 2019
Takeda's dengue vaccine said effective overall in study but with major limitation
Takeda Pharmaceutical Co.'s experimental dengue vaccine was highly effective at preventing the mosquito-borne disease in a late stage study, but it failed to protect against one type of the virus in people with no prior exposure to dengue.
Japan Times
BUSINESS / Companies
Oct 11, 2019
Takeda nears deal on sale of Russia, Mideast and Africa assets to private equity firms
Takeda Pharmaceutical Co. is nearing the sale of a portfolio of assets in the Middle East, Africa and Russia to separate buyout firms that could help the drugmaker raise about $1 billion to reduce debt, according to people familiar with the matter.
Japan Times
JAPAN
Oct 1, 2019
National Public Safety Commission tackles topics from elderly driving to Tokyo Olympics security
The government will consider various measures to prevent traffic accidents involving elderly drivers, including the introduction of a new driver's license category with special limitations, National Public Safety Commission Chairman Ryota Takeda has said.
Japan Times
BUSINESS / Companies
Sep 27, 2019
Takeda Pharmaceutical to sell drug assets in emerging markets and Europe, sources say
Takeda Pharmaceutical Co. is close to selling some assets in emerging markets and Western Europe, people familiar with the matter said, in a move that would help the Japanese drugmaker reduce its debt pile.
Japan Times
OLYMPICS
Aug 28, 2019
French investigators focus on Dentsu partner in sports corruption probe
French authorities investigating corruption in international sports believe a Swiss partner of Japanese advertising giant Dentsu Inc. played a "central and essential role" in deals used to embezzle sponsorship money and have asked Switzerland to raid its office and seize evidence, according to a person with knowledge of the probe and documents related to the case reviewed by Reuters.
Japan Times
OLYMPICS
Jun 27, 2019
Judo great Yasuhiro Yamashita replaces scandal-hit Tsunekazu Takeda as Japanese Olympic Committee chief
Yamashita will replace Tsunekazu Takeda who retired as JOC president amid an investigation over alleged bribery during Tokyo's bid to host the Tokyo 2020 Olympic and Paralympic Games.
Japan Times
JAPAN / Science & Health
Jun 11, 2019
As its drug firms consider move to Tokyo, does Osaka have a future as a modern city of medicine?
The Doshomachi area of the city of Osaka has been the home and birthplace of many pharmaceutical companies since the Edo Period (1603-1868), including some of the leading drugmakers such as Ono Pharmaceutical Co.

Longform

Rows of irises resemble a rice field at the Peter Walker-designed Toyota Municipal Museum of Art.
The 'outsiders' creating some of Japan's greenest spaces